<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 82-year-old man developed severe, <z:hpo ids='HP_0011009'>acute</z:hpo>, predominantly <z:hpo ids='HP_0007178'>motor polyneuropathy</z:hpo>, signs of autonomic involvement, and skin changes following <z:chebi fb="0" ids="17549">aminolevulinic acid</z:chebi> (ALA) administration </plain></SENT>
<SENT sid="1" pm="."><plain>The compound was used as a <z:chebi fb="0" ids="50266">prodrug</z:chebi> for photodynamic therapy of Barrett's <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Changes were observed in various parameters of the <z:chebi fb="4" ids="30413">heme</z:chebi> pathway </plain></SENT>
<SENT sid="3" pm="."><plain>The case reported represents a rare response to ALA treatment, resembling an <z:hpo ids='HP_0011009'>acute</z:hpo> attack of hepatic <z:mp ids='MP_0005654'>porphyria</z:mp> with neurological features </plain></SENT>
</text></document>